Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Lymphoma, Non-Hodgkin × sargramostim × Clear all

Phase

Phase 2 16 Phase 1 5 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Breast Neoplasms 5 Colorectal Neoplasms 4 Ovarian Neoplasms 3 Neuroblastoma 3 Neoplasm Metastasis 3 Uveal Melanoma 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Neoplasms 2 Multiple Myeloma 2 Lymphoma 2 Lung Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1

Interventions

Rituximab 50 Cyclophosphamide 38 fludarabine 22 fludarabine phosphate 17 Peripheral Blood Stem Cell Transplantation 17 Melphalan 13 Whole-Body Irradiation 11 Mycophenolic Acid 11 Lenalidomide 11 Etoposide 11 venetoclax 10 Vincristine 10 Prednisone 10 obinutuzumab 9 Doxorubicin 9 Cytarabine 9 Cyclosporine 9 Bortezomib 9 Filgrastim 8 Busulfan 7 Bendamustine Hydrochloride 7 Tacrolimus 6 Nivolumab 6 Interleukin-2 6 Gemcitabine 6 Dexamethasone 6 Carmustine 6 Alemtuzumab 6 pembrolizumab 5 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01527422 2012-02-07

CHOP-R

Auxilio Mutuo Cancer Center

Phase 1/2 Completed

Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡